Renaissance Technologies
LKFT

Renaissance Technologies’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Renaissance Technologies’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.46M Buy
315,400
+4,800
+2% +$159K 0.01% 996
2025
Q4 		$10.2M Sell
310,600
-45,600
-13% -$1.47M 0.02% 909
2025
Q3 		$12.3M Sell
356,200
-108,500
-23% -$3.47M 0.02% 984
2025
Q2 		$13M Buy
464,700
+133,900
+40% +$3.59M 0.02% 913
2025
Q1 		$8.31M Buy
330,800
+34,700
+12% +$877K 0.01% 1107
2024
Q4 		$8.14M Buy
296,100
+4,421
+2% +$123K 0.01% 1142
2024
Q3 		$8.4M Buy
291,679
+20,879
+8% +$569K 0.01% 1131
2024
Q2 		$6.71M Buy
270,800
+4,300
+2% +$122K 0.01% 1131
2024
Q1 		$8.58M Buy
266,500
+3,300
+1% +$123K 0.01% 1079
2023
Q4 		$10.7M Sell
263,200
-18,600
-7% -$684K 0.02% 914
2023
Q3 		$9.74M Sell
281,800
-26,100
-8% -$1.02M 0.02% 940
2023
Q2 		$12.5M Sell
307,900
-50,500
-14% -$2.06M 0.02% 911
2023
Q1 		$13.8M Buy
358,400
+22,020
+7% +$905K 0.02% 911
2022
Q4 		$14.9M Buy
336,380
+37,780
+13% +$1.59M 0.02% 871
2022
Q3 		$12.7M Buy
298,600
+50,300
+20% +$2.58M 0.02% 898
2022
Q2 		$13.9M Buy
248,300
+163,800
+194% +$9.71M 0.02% 935
2022
Q1 		$5.24M Buy
84,500
+27,900
+49% +$1.71M 0.01% 1559
2021
Q4 		$3.12M Buy
56,600
+5,700
+11% +$297K ﹤0.01% 1827
2021
Q3 		$2.68M Buy
50,900
+40,700
+399% +$2.42M ﹤0.01% 1874
2021
Q2 		$703K Sell
10,200
-500
-5% -$38.1K ﹤0.01% 2819
2021
Q1 		$825K Sell
10,700
-64,210
-86% -$5.92M ﹤0.01% 2691
2020
Q4 		$7.42M Sell
74,910
-105,090
-58% -$12.9M 0.01% 1350
2020
Q3 		$25.5M Sell
180,000
-81,200
-31% -$13.5M 0.03% 621
2020
Q2 		$51.5M Buy
261,200
+26,008
+11% +$5.39M 0.04% 419
2020
Q1 		$46.1M Buy
235,192
+233,792
+16,699% +$50.3M 0.04% 413
2019
Q4 		$290K Buy
+1,400
New +$259K ﹤0.01% 3081
2019
Q3 		– Sell
-30,500
Closed -$3.93M – 3517
2019
Q2 		$3.93M Sell
30,500
-22,600
-43% -$2.68M ﹤0.01% 1948
2019
Q1 		$6.25M Sell
53,100
-8,600
-14% -$867K 0.01% 1667
2018
Q4 		$5.66M Sell
61,700
-60,600
-50% -$6.14M 0.01% 1636
2018
Q3 		$13.8M Sell
122,300
-52,730
-30% -$5.57M 0.01% 1146
2018
Q2 		$16.1M Sell
175,030
-52,070
-23% -$5.05M 0.02% 1054
2018
Q1 		$22.7M Sell
227,100
-8,100
-3% -$873K 0.02% 866
2017
Q4 		$22.1M Sell
235,200
-31,300
-12% -$2.96M 0.02% 878
2017
Q3 		$27.1M Sell
266,500
-198,800
-43% -$17.4M 0.03% 718
2017
Q2 		$35.6M Buy
465,300
+154,100
+50% +$13M 0.05% 522
2017
Q1 		$26.8M Buy
311,200
+105,700
+51% +$7.61M 0.04% 632
2016
Q4 		$13.2M Buy
205,500
+65,300
+47% +$4.02M 0.02% 1047
2016
Q3 		$9.06M Buy
140,200
+132,100
+1,631% +$7.44M 0.02% 1199
2016
Q2 		$449K Buy
+8,100
New +$407K ﹤0.01% 2830
2016
Q1 		– Sell
-37,900
Closed -$2.38M – 3422
2015
Q4 		$2.38M Buy
+37,900
New +$1.94M 0.01% 2000

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies's LKFT Position: Q1 2026 in Review

Renaissance Technologies increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 1.5% in Q1 2026, buying an estimated $159K and bringing the position to 315,400 shares worth $9.46M. The position accounts for 0.01% of the portfolio, ranked #996.

Renaissance Technologies first reported a position in LKFT in Q4 2015 and has held it in 40 quarters since. The position peaked at $51.5M in Q2 2020. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

  • Renaissance Technologies held 315,400 shares of Lakefront Biotherapeutics American Depositary Shares worth $9.46M as of Q1 2026.
  • Renaissance Technologies bought 4,800 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $159K.
  • Lakefront Biotherapeutics American Depositary Shares made up 0.01% of Renaissance Technologies's portfolio in Q1 2026, its #996 holding.
  • Renaissance Technologies first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2015 and has held it in 40 quarters since.
  • Renaissance Technologies's Lakefront Biotherapeutics American Depositary Shares position peaked at $51.5M in Q2 2020.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.